MedTrace Logo

Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.

NCT04920513 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2025-03-19

No results posted yet for this study

Summary

The investigators aim to study the pattern and frequency of pathogenic variants among ALL newly diagnosed cancer patients in a genetically distinct population.

Additionally, the investigators will study the uptake rate of "cascade family screening", frequency of pathogenic variants and barriers against testing.

Conditions

  • Genetic Predisposition

Sponsors & Collaborators

  • King Hussein Cancer Center

    lead OTHER

Principal Investigators

  • Hikmat Abdel-Razeq · King Hussein Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2025-02-01
Completion
2025-02-01

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04920513 on ClinicalTrials.gov